Jove
Visualize
Contact Us

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention study.

Lancet (London, England)·2025
Same author

Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis.

PloS one·2022
Same author

The legacy of ZikaPLAN: a transnational research consortium addressing Zika.

Global health action·2022
Same author

Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system.

Arquivos de neuro-psiquiatria·2021
Same author

SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.

Frontiers in immunology·2021
Same author

Peripheral spectrum neurological disorder after arbovirus infection is associated with HLA-F variants among Northeastern Brazilians.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 10, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Cognitive deficits in multiple sclerosis: a systematic review.

Maria Lúcia Brito Ferreira1

  • 1Neurology Department, Hospital da Restauração, Recife, PE, Brazil. lucabrito@uol.com.br

Arquivos De Neuro-Psiquiatria
|August 24, 2010
PubMed
Summary

Multiple sclerosis patients frequently experience cognitive dysfunction, particularly in memory and processing speed. Standardized neuropsychological testing is needed for consistent evaluation and diagnosis.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Experiment Videos

Last Updated: Jun 10, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Psychology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease affecting the central nervous system.
  • Cognitive impairments are a common and significant challenge for individuals with MS, impacting daily functioning.
  • Existing research highlights the need for standardized methods to assess cognitive deficits in MS patients.

Purpose of the Study:

  • To review and synthesize findings from prospective and retrospective studies on cognitive dysfunctions in multiple sclerosis patients.
  • To analyze the variety of neuropsychological test batteries and individual tests employed in multiple sclerosis research.
  • To discuss the implications of current testing practices for the diagnostic routine of cognitive impairment in MS.

Main Methods:

  • A systematic review of 40 studies published between 1997 and 2009 was conducted.
  • Searches were performed across major scientific databases including PubMed, Scopus, Ovid, Web of Science, SciELO, and LILACS.
  • Inclusion criteria focused on studies providing clear descriptions of cognitive deficit evaluation, methodology, and statistical analysis in MS patients.

Main Results:

  • A strong consensus exists regarding the prevalence of cognitive impairment in multiple sclerosis, affecting domains such as memory, processing speed, executive functions, attention, and concentration.
  • A wide array of 23 distinct test batteries and 74 individual neuropsychological tests were identified across the reviewed studies.
  • The Consortium of Multiple Sclerosis Centers' recommended MACFIMS (Minimal Assessment Cognitive Function in MS) battery was not consistently utilized.

Conclusions:

  • The lack of a standardized, uniform neuropsychological test battery for evaluating cognitive function in multiple sclerosis patients has hindered the establishment of evidence-based recommendations for routine diagnostic use.
  • Despite the current heterogeneity, there is a discernible trend towards adopting more standardized assessment approaches in multiple sclerosis research and clinical practice.
  • Further research and consensus-building are necessary to implement a universally accepted cognitive evaluation protocol for multiple sclerosis.